TW202334179A - 胜肽 - Google Patents

胜肽 Download PDF

Info

Publication number
TW202334179A
TW202334179A TW111137268A TW111137268A TW202334179A TW 202334179 A TW202334179 A TW 202334179A TW 111137268 A TW111137268 A TW 111137268A TW 111137268 A TW111137268 A TW 111137268A TW 202334179 A TW202334179 A TW 202334179A
Authority
TW
Taiwan
Prior art keywords
peptide
amino acid
tgf
seq
group
Prior art date
Application number
TW111137268A
Other languages
English (en)
Chinese (zh)
Inventor
鈴木芳典
杵渕政彦
Original Assignee
日商肽夢想股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商肽夢想股份有限公司 filed Critical 日商肽夢想股份有限公司
Publication of TW202334179A publication Critical patent/TW202334179A/zh

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW111137268A 2021-09-30 2022-09-30 胜肽 TW202334179A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021-161353 2021-09-30
JP2021161353 2021-09-30

Publications (1)

Publication Number Publication Date
TW202334179A true TW202334179A (zh) 2023-09-01

Family

ID=85780814

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111137268A TW202334179A (zh) 2021-09-30 2022-09-30 胜肽

Country Status (10)

Country Link
US (1) US20250034212A1 (cg-RX-API-DMAC7.html)
EP (1) EP4410816A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2023054712A1 (cg-RX-API-DMAC7.html)
KR (1) KR20240082377A (cg-RX-API-DMAC7.html)
CN (1) CN118103387A (cg-RX-API-DMAC7.html)
AU (1) AU2022355276A1 (cg-RX-API-DMAC7.html)
CA (1) CA3234324A1 (cg-RX-API-DMAC7.html)
IL (1) IL311773A (cg-RX-API-DMAC7.html)
TW (1) TW202334179A (cg-RX-API-DMAC7.html)
WO (1) WO2023054712A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024347940A1 (en) * 2023-09-29 2026-04-30 Peptidream Inc. Peptide
WO2025100520A1 (ja) * 2023-11-10 2025-05-15 ペプチドリーム株式会社 ペプチド、ペプチド複合体、医薬組成物、細胞培養用組成物、及び医療用、診断用又は研究用に用いられる組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240912A (en) * 1983-05-09 1993-08-31 Todaro George J Transforming growth factor (TGF) peptides
US5525491A (en) 1991-02-27 1996-06-11 Creative Biomolecules, Inc. Serine-rich peptide linkers
PT1263464E (pt) * 2000-03-09 2012-12-17 Genzyme Corp Utilização de anticorpos anti-tgf-beta antagonistas para tratar ou para prevenir a perda da função renal
SI1724284T1 (sl) 2000-12-07 2009-12-31 Lilly Co Eli Glp-1 fuzijski proteini
CA2484994C (en) * 2002-04-29 2016-06-14 St. Louis University Peptide antagonists of tgf-beta family members and therapeutic uses thereof
EP1964916B1 (en) 2005-12-06 2012-08-01 The University of Tokyo Multi-purpose acylation catalayst and use thereof
EP2419116A1 (en) * 2009-04-13 2012-02-22 North Western University Novel peptide-based scaffolds for cartilage regeneration and methods for their use
CA2809568C (en) 2010-09-01 2019-06-11 Genzyme Corporation Treatment of myocardial infarction using tgf - beta antagonists
PL3089971T3 (pl) 2014-01-01 2021-01-25 Medivation Technologies Llc Związki i sposoby ich zastosowania
WO2017024407A1 (en) * 2015-08-11 2017-02-16 The Royal Institution For The Advancement Of Learning/Mcgill University Peptidic tgf-beta antagonists
KR102631542B1 (ko) * 2018-03-14 2024-02-01 서울대학교산학협력단 염증 감소능 및 줄기세포로부터 연골세포로의 분화 촉진능을 가지는 이중 기능성 펩타이드 및 이의 용도
JP6952747B2 (ja) 2018-09-18 2021-10-20 ファイザー・インク がん処置のためのTGFβ阻害剤およびCDK阻害剤の組合せ
EP4410958A4 (en) * 2021-09-30 2025-11-12 Jsr Corp PROCESS FOR THE PRODUCTION OF ORGANOIDS, CULTURE MEDIUM FOR THE PRODUCTION OF ORGANOIDS, ORGANOID AND PROCESS FOR EVALUATING TEST SUBSTANCE

Also Published As

Publication number Publication date
CA3234324A1 (en) 2023-04-06
AU2022355276A1 (en) 2024-05-16
JPWO2023054712A1 (cg-RX-API-DMAC7.html) 2023-04-06
WO2023054712A1 (ja) 2023-04-06
IL311773A (en) 2024-05-01
CN118103387A (zh) 2024-05-28
EP4410816A4 (en) 2025-11-19
EP4410816A1 (en) 2024-08-07
US20250034212A1 (en) 2025-01-30
KR20240082377A (ko) 2024-06-10

Similar Documents

Publication Publication Date Title
WO2021167107A1 (ja) ヒトトランスフェリンレセプター結合ペプチド
TW202304947A (zh) 胜肽及包含胜肽之組成物
EP4410816A1 (en) Peptide
JP7854211B2 (ja) ヘマグルチニン結合ペプチド
JPWO2016063969A1 (ja) ヘマグルチニン結合ペプチド
TW202321274A (zh) 人類運鐵蛋白受體結合肽
TW202434613A (zh) 人類運鐵蛋白受體結合肽
HK40105341A (en) Human transferrin receptor–binding peptide
US20250282820A1 (en) Peptide complex having trkb binding activity
CN121925425A (zh) 肽
JP2024523280A (ja) Ghr結合ペプチドおよびそれを含む組成物
HK40057758B (zh) 血球凝集素结合肽
HK40105891A (en) Human transferrin receptor-binding antibody-peptide conjugate
WO2025047927A1 (ja) Vegfr-2アゴニスト活性を有するペプチド複合体
JP2026510340A (ja) 呼吸器合胞体ウイルス表面糖タンパク質ペプチド、コンジュゲート、及びその使用
CN117858889A (zh) 肽及包含肽的组合物
TW202305012A (zh) c-Met 蛋白質結合肽複合物
HK40057758A (en) Hemagglutinin-binding peptide
Parlak Peptide-based drug systems